Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-082541
Filing Date
2025-06-05
Accepted
2025-06-05 17:31:16
Documents
1
Period of Report
2025-06-03

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3739
  Complete submission text file 0000950170-25-082541.txt   5196
Mailing Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803
Business Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Issuer) CIK: 0001604950 (see all company filings)

EIN.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SCPHARMACEUTICALS, INC. 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01830
Business Address
Agger Mette Kirstine (Reporting) CIK: 0001722234 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38293 | Film No.: 251028304